The MHRA Papers - Part 2
We have some questions, but there is no formal obligation to reply
We continue reviewing the minutes of the three meetings of the MHRA’s Commission On Human Medicines (CHM) COVID-19 Vaccines Benefit Risk Expert Working Group, which took place between 28 October an…
